
Definium Therapeutics, Inc.
USD45.08
+2.28 (+5.33%)
CEO
Robert Barrow
IPO Date
2016-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$42.50
Prev. Close
$42.80
Day Low
$41.57
Day High
$45.17
52W Low
$12.88
52W High
$49.20
Market Cap
$4.92B
Volume
1.15M
| 23 Jun 2026 |
| Needham |
| Buy |
| Buy |
| maintain |
| 23 Jun 2026 | Baird | Outperform | Outperform | maintain |
| 22 Jun 2026 | Oppenheimer | Outperform | Outperform | maintain |
| 22 Jun 2026 | Leerink Partners | Outperform | Outperform | maintain |
| 16 Jun 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 8 May 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 22 Apr 2026 | Leerink Partners | Outperform | Outperform | maintain |